Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HEXA | P06865 | 1/20 | 0.32 |
| ▸ | HEXB | P07686 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19370740 | 0.78 | ALDH1A1 (0.32) | KDM4EHEXAHEXBALDH1A1MAPT | |
| SCHEMBL18927984 | 0.76 | GBA1 (0.39) | KDM4EL3MBTL1ALDH1A1 | |
| SCHEMBL10458192 | 0.73 | L3MBTL1 (0.38) | KDM4EL3MBTL1KMT2A | |
| SCHEMBL19820112 | 0.72 | GBA1 (0.33) | — | |
| SCHEMBL8422483 | 0.72 | SMN1; SMN2 (0.34) | KDM4EHEXAHEXBL3MBTL1ALDH1A1 | |
| SCHEMBL18106281 | 0.70 | L3MBTL1 (0.50) | KDM4EL3MBTL1KMT2ALMNASMN1; SMN2 | |
| SCHEMBL11764937 | 0.70 | L3MBTL1 (0.33) | L3MBTL1ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL18500859 | 0.69 | FAAH (0.33) | — | |
| SCHEMBL11056809 | 0.69 | KDM4E (0.33) | KDM4EALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL11328124 | 0.68 | L3MBTL1 (0.34) | KDM4EL3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793731-B2 | Multi-part dental composition having staged viscosity prior to hardening | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-10-24 | — | — | US | disclosed |
| US-20200383877-A1 | MULTI-PART DENTAL COMPOSITION HAVING STAGED VISCOSITY PRIOR TO HARDENING | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2020-12-10 | — | — | US | disclosed |
| US-10196481-B2 | Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof | SIRRUS, INC. (US) | 2019-02-05 | — | — | US | disclosed |
| US-20170349700-A1 | POLYMER AND OTHER COMPOUNDS FUNCTIONALIZED WITH TERMINAL 1,1-DISUBSTITUTED ALKENE MONOMER(S) AND METHODS THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200383877-A1 | MULTI-PART DENTAL COMPOSITION HAVING STAGED VISCOSITY PRIOR TO HARDENING | POLR1A, POLR2A, POLR2H | KDM4E 3203/4885HEXA 3677/4885HEXB 3732/4885 |
| US-11793731-B2 | Multi-part dental composition having staged viscosity prior to hardening | POLR1A, POLR2A, POLR2H | KDM4E 3203/4885HEXA 3677/4885HEXB 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.